… decrease morbidity and mortality in IS treated mice, we infected IS mice as described above
… Weight loss and mortality were monitored for 21 days. All placebo-treated infected IS mice …

… Interestingly, despite these potential limitations, our results show that chronic EtOH exposed
mice treated with oseltamivir are protected from increased morbidity and mortality as well as …

… of oseltamivir in terms of survival, lung viral load, injury to the alveolar-capillary barrier, and
inflammation in BALB/c mice after infection with mouse-… effective as oseltamivir in improving …

… The A/HK-H275Y model is also useful but we found that variable mortality occurred from
experiment to experiment (the studies presented here were acceptable, but other unreported …

… Against the H3N2 infection, there were insignificant decreases in mortality at the 2-mg/kg/day
dose compared to the H1N1pdm study. In addition, body weight losses in groups treated …

… morbidity and mortality in immunosuppressed mice, BR/08 … lethality in mice inoculated with
at least 10 3 TCID 50 /mouse. … mice, but the extent of pulmonary inflammation in these mice …

… sometimes result in mortality. In these studies, we excluded two mice that died during the …
with these or related viruses with either oseltamivir or favipiravir monotherapy prior to these …

… antiviral plus immunomodulator treatment still reduces mortality in mice infected by high
inoculum of influenza A/H5N1 virus. Proc Natl Acad Sci USA 105:8091–8096 [View Article]…

… Thus, we questioned if oseltamivir treatment of OB mice would … In these studies, we
treated OB mice with the NAI oseltamivir … mortality: a modelling study. Lancet 391:1285–1300. …

… % mortality was observed on day 9 after infection. Prophylactic treatment with oseltamivir
significantly delayed mortality … treatment with oseltamivir significantly delayed mortality by 1 day …